Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03023046
Title Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

acute lymphoblastic leukemia

lymphoblastic lymphoma

Therapies

Rituximab

Doxorubicin

Etoposide

Imatinib

Dasatinib

Cyclophosphamide

Prednisone

Vincristine Sulfate

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.